The CDC's vaccine advisory committee, now with RFK Jr.-appointed members, recommended a new RSV monoclonal antibody shot for infants under 8 months. A 5-2 vote favored Merck's clesrovimab for infants not protected by maternal vaccines. The committee also unanimously updated the Vaccines for Children program to include this shot. The decision awaits final approval from Health and Human Services Secretary Robert F. Kennedy Jr., as there's currently no CDC director. The meeting also reviewed the childhood immunization schedule, prompting concerns and alternative recommendations from the American Academy of Pediatrics.

Prepared by Olivia Bennett and reviewed by editorial team.